HHTM

BOSTON, MASS. — A new real-world analysis of 97 U.S. patients with bothersome tinnitus treated with Lenire, an FDA-approved bimodal neuromodulation device, has been made available on medRxiv, a preprint server for health sciences. The paper, titled “First Real-World Evidence Utilizing the Multidimensional Tinnitus Functional Index to Assess Treatment Impact with Bimodal Neuromodulation,” reports outcomes measured using both the Tinnitus

ITASCA, ILLINOIS — Knowles Corporation has announced the availability of a new family of multi-way balanced armature (BA) driver combinations aimed at simplifying the development of premium in-ear monitors (IEMs), gaming earphones, and high-resolution audio products. The new driver family features pre-configured multi-driver combinations with integrated crossover circuits, designed to reduce development complexity while supporting consistent, high-performance audio output. Simplifying

MindEar, a digital tinnitus support platform, is offering a free one-week trial of its guided “Sound Wellness Challenge” during Tinnitus Awareness Week 2026 (February 2–9). The company says the seven-day program is designed to help participants try evidence-informed strategies that may reduce tinnitus distress, including sound-based tools, attention and stress regulation techniques, and habit-building approaches that support sleep and daytime

What makes tinnitus distressing for some people—but barely noticeable for others? In this in-depth conversation, clinical psychologist and tinnitus researcher Dr. Jennifer Gans explains why tinnitus is best understood not simply as a sound, but as a brain-driven experience. Drawing on neuroscience, clinical experience, and mindfulness-based research, she explores how the brain’s response—rather than the sound itself—plays a central role

BALLERUP, DENMARK – GN announced additions to its ReSound hearing aid portfolio alongside updates to its fitting software, including new custom in-the-canal styles and enhancements to ReSound Smart Fit. The updates are intended to broaden device form factor options and provide hearing care professionals with additional fitting tools. New Custom In-the-Canal Styles and Connectivity GN is expanding the ReSound Savi essential

by Paul A. Fagan, AM MD (Honoris Causa) FRCS FRACS; Isobel R. O’Loughlin, BHlthMedSc(Adv) M.ClinAud Acoustic Shock Syndrome—also referred to as Tonic Tensor Tympani Syndrome—has been described in individuals exposed to sudden, unexpected high-pitched sounds through telephone headsets or similar devices, most commonly in occupational settings such as call centers. These sounds, while typically brief and well below established safety

A new observational study suggests that individuals with primary subjective tinnitus are significantly more likely to have low levels of 25-hydroxyvitamin D3 compared with individuals without tinnitus, and that deficiency may be associated with greater tinnitus severity and chronicity. The findings, published in Frontiers in Neurology, add to a growing body of evidence linking vitamin D status to inner ear

WASHINGTON, D.C. — U.S. Senators Adam Schiff (D-Calif.), Marsha Blackburn (R-Tenn.), and Chuck Grassley (R-Iowa) have introduced the Veterans Hearing Aid Improvement Act, bipartisan legislation intended to improve access to hearing aids for eligible veterans through the U.S. Department of Veterans Affairs (VA). The proposed bill would authorize a two-year pilot program allowing the VA to evaluate the use of

WASHINGTON, D.C. — The ACI Alliance has announced that Dr. James A. Robinson, 2024 Nobel Laureate in Economic Sciences, will deliver a keynote lecture at CI2026 Chicago, the international cochlear implant conference scheduled to take place in Chicago in May 2026. Dr. Robinson’s keynote, titled “Why Proven Technologies Fail to Spread: Institutions, Incentives, and the Case of Hearing Health,” will

AURORA, ILLINOIS — Tinnitus affects millions of patients worldwide and remains one of the most challenging auditory conditions to manage. In recognition of the annual Tinnitus Awareness Week, AudioNova emphasized a patient-centered, holistic approach—framing tinnitus not as an independent disease, but as a symptom with variable individual manifestation. Current evidence supports a multimodal treatment pathway that can include education, individualized